Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer

NCT02000193 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: fulvestrant

Sponsor

Sun Yat-sen University

Collaborators

[object Object]